Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation

Paul L. Severson, Erik J. Tokar, Lukas Vrba, Michael P. Waalkes, Bernard W Futscher

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Epigenetic dysfunction is a known contributor in carcinogenesis, and is emerging as a mechanism involved in toxicantinduced malignant transformation for environmental carcinogens such as arsenicals or cadmium. In addition to aberrant DNA methylation of single genes, another manifestation of epigenetic dysfunction in cancer is agglomerative DNA methylation, which can participate in long-range epigenetic silencing that targets many neighboring genes and has been shown to occur in several types of clinical cancers. Using in vitro model systems of toxicant-induced malignant transformation, we found hundreds of aberrant DNA methylation events that emerge during malignant transformation, some of which occur in an agglomerative fashion. In an arsenite-transformed prostate epithelial cell line, the protocadherin (PC DH), HOXC and HOXD gene family clusters are targeted for agglomerative DNA methylation. The agglomerative DNA methylation changes induced by arsenicals appear to be common and clinically relevant events, since they occur in other human cancer cell lines and models of malignant transformation, as well as clinical cancer specimens. Aberrant DNA methylation in general occurred more often within histone H3 lysine-27 trimethylation stem cell domains. We found a striking association between enrichment of histone H3 lysine-9 trimethylation stem cell domains and toxicant-induced agglomerative DNA methylation, suggesting these epigenetic modifications may become aberrantly linked during malignant transformation. In summary, we found an association between toxicant-induced malignant transformation and agglomerative DNA methylation, which lends further support to the hypothesis that epigenetic dysfunction plays an important role in toxicant-induced malignant transformation.

Original languageEnglish (US)
Pages (from-to)1238-1248
Number of pages11
JournalEpigenetics
Volume7
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

DNA Methylation
Epigenomics
Arsenicals
Histones
Lysine
Neoplasms
Stem Cells
Environmental Carcinogens
Cell Line
Multigene Family
Cadmium
Genes
Prostate
Carcinogenesis
Epithelial Cells

Keywords

  • Agglomerative DNA methylation
  • Arsenic
  • Cadmium
  • DNA methylation
  • Epigenetics
  • H3K27me3
  • H3K9me3
  • Long-range epigenetic silencing
  • Malignant transformation

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation. / Severson, Paul L.; Tokar, Erik J.; Vrba, Lukas; Waalkes, Michael P.; Futscher, Bernard W.

In: Epigenetics, Vol. 7, No. 11, 11.2012, p. 1238-1248.

Research output: Contribution to journalArticle

Severson, Paul L. ; Tokar, Erik J. ; Vrba, Lukas ; Waalkes, Michael P. ; Futscher, Bernard W. / Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation. In: Epigenetics. 2012 ; Vol. 7, No. 11. pp. 1238-1248.
@article{be6f74053e5a46e5baa628f4b749841e,
title = "Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation",
abstract = "Epigenetic dysfunction is a known contributor in carcinogenesis, and is emerging as a mechanism involved in toxicantinduced malignant transformation for environmental carcinogens such as arsenicals or cadmium. In addition to aberrant DNA methylation of single genes, another manifestation of epigenetic dysfunction in cancer is agglomerative DNA methylation, which can participate in long-range epigenetic silencing that targets many neighboring genes and has been shown to occur in several types of clinical cancers. Using in vitro model systems of toxicant-induced malignant transformation, we found hundreds of aberrant DNA methylation events that emerge during malignant transformation, some of which occur in an agglomerative fashion. In an arsenite-transformed prostate epithelial cell line, the protocadherin (PC DH), HOXC and HOXD gene family clusters are targeted for agglomerative DNA methylation. The agglomerative DNA methylation changes induced by arsenicals appear to be common and clinically relevant events, since they occur in other human cancer cell lines and models of malignant transformation, as well as clinical cancer specimens. Aberrant DNA methylation in general occurred more often within histone H3 lysine-27 trimethylation stem cell domains. We found a striking association between enrichment of histone H3 lysine-9 trimethylation stem cell domains and toxicant-induced agglomerative DNA methylation, suggesting these epigenetic modifications may become aberrantly linked during malignant transformation. In summary, we found an association between toxicant-induced malignant transformation and agglomerative DNA methylation, which lends further support to the hypothesis that epigenetic dysfunction plays an important role in toxicant-induced malignant transformation.",
keywords = "Agglomerative DNA methylation, Arsenic, Cadmium, DNA methylation, Epigenetics, H3K27me3, H3K9me3, Long-range epigenetic silencing, Malignant transformation",
author = "Severson, {Paul L.} and Tokar, {Erik J.} and Lukas Vrba and Waalkes, {Michael P.} and Futscher, {Bernard W}",
year = "2012",
month = "11",
doi = "10.4161/epi.22163",
language = "English (US)",
volume = "7",
pages = "1238--1248",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Landes Bioscience",
number = "11",

}

TY - JOUR

T1 - Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation

AU - Severson, Paul L.

AU - Tokar, Erik J.

AU - Vrba, Lukas

AU - Waalkes, Michael P.

AU - Futscher, Bernard W

PY - 2012/11

Y1 - 2012/11

N2 - Epigenetic dysfunction is a known contributor in carcinogenesis, and is emerging as a mechanism involved in toxicantinduced malignant transformation for environmental carcinogens such as arsenicals or cadmium. In addition to aberrant DNA methylation of single genes, another manifestation of epigenetic dysfunction in cancer is agglomerative DNA methylation, which can participate in long-range epigenetic silencing that targets many neighboring genes and has been shown to occur in several types of clinical cancers. Using in vitro model systems of toxicant-induced malignant transformation, we found hundreds of aberrant DNA methylation events that emerge during malignant transformation, some of which occur in an agglomerative fashion. In an arsenite-transformed prostate epithelial cell line, the protocadherin (PC DH), HOXC and HOXD gene family clusters are targeted for agglomerative DNA methylation. The agglomerative DNA methylation changes induced by arsenicals appear to be common and clinically relevant events, since they occur in other human cancer cell lines and models of malignant transformation, as well as clinical cancer specimens. Aberrant DNA methylation in general occurred more often within histone H3 lysine-27 trimethylation stem cell domains. We found a striking association between enrichment of histone H3 lysine-9 trimethylation stem cell domains and toxicant-induced agglomerative DNA methylation, suggesting these epigenetic modifications may become aberrantly linked during malignant transformation. In summary, we found an association between toxicant-induced malignant transformation and agglomerative DNA methylation, which lends further support to the hypothesis that epigenetic dysfunction plays an important role in toxicant-induced malignant transformation.

AB - Epigenetic dysfunction is a known contributor in carcinogenesis, and is emerging as a mechanism involved in toxicantinduced malignant transformation for environmental carcinogens such as arsenicals or cadmium. In addition to aberrant DNA methylation of single genes, another manifestation of epigenetic dysfunction in cancer is agglomerative DNA methylation, which can participate in long-range epigenetic silencing that targets many neighboring genes and has been shown to occur in several types of clinical cancers. Using in vitro model systems of toxicant-induced malignant transformation, we found hundreds of aberrant DNA methylation events that emerge during malignant transformation, some of which occur in an agglomerative fashion. In an arsenite-transformed prostate epithelial cell line, the protocadherin (PC DH), HOXC and HOXD gene family clusters are targeted for agglomerative DNA methylation. The agglomerative DNA methylation changes induced by arsenicals appear to be common and clinically relevant events, since they occur in other human cancer cell lines and models of malignant transformation, as well as clinical cancer specimens. Aberrant DNA methylation in general occurred more often within histone H3 lysine-27 trimethylation stem cell domains. We found a striking association between enrichment of histone H3 lysine-9 trimethylation stem cell domains and toxicant-induced agglomerative DNA methylation, suggesting these epigenetic modifications may become aberrantly linked during malignant transformation. In summary, we found an association between toxicant-induced malignant transformation and agglomerative DNA methylation, which lends further support to the hypothesis that epigenetic dysfunction plays an important role in toxicant-induced malignant transformation.

KW - Agglomerative DNA methylation

KW - Arsenic

KW - Cadmium

KW - DNA methylation

KW - Epigenetics

KW - H3K27me3

KW - H3K9me3

KW - Long-range epigenetic silencing

KW - Malignant transformation

UR - http://www.scopus.com/inward/record.url?scp=84868349976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868349976&partnerID=8YFLogxK

U2 - 10.4161/epi.22163

DO - 10.4161/epi.22163

M3 - Article

C2 - 22976526

AN - SCOPUS:84868349976

VL - 7

SP - 1238

EP - 1248

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 11

ER -